Omicron News and Research

RSS

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

A new preprint describes a single-step molecular diagnostic test for the presence of SARS-CoV-2 infection caused by the Omicron variant that is behind the unprecedented rise in cases over the last few weeks.

11 Jan 2022

Evaluating effectiveness of the COVID-19 mRNA-1273 vaccine against Omicron and Delta variants

Researchers recently assessed vaccine effectiveness against Omicron and Delta variant-induced infection as well as hospitalization, including among immunocompromised individuals.

11 Jan 2022

Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant

The current study examines the role of heterologous vaccination, an area that lacks much clarity.

11 Jan 2022

Fire closes hospital and displaces staff as Colorado battles omicron

The Colorado wildfire that destroyed more than 1,000 homes last month has forced the temporary closure of a hospital and upended the lives of health care workers as the state's already strained health care system braces for another surge in covid-19 hospitalizations.

11 Jan 2022

Development and validation of 2-gene host-based COVID-19 diagnostic classifiers

A group of researchers from Biohub has been attempting to create a more accurate method for PCR testing.

11 Jan 2022

Providing recombinant antibody services and more within Europe

In this interview, News-Medical talks to Dr. Zhang Linlin, Technical Specialist at Sino Biological Europe, about their recombinant antibody services and more that they can provide within Europe. Image credit: Corona Borealis Studio/Shutterstock.com

From Sino Biological Inc. 11 Jan 2022

New insights into reforming the actions that hindered Seattle researchers from community testing for COVID-19

As the two-year anniversary of the pandemic approaches, a new commentary provides insights into reforming the "labyrinth of conflicting and uncoordinated actions among state and federal regulators" that in early 2020 hampered Seattle researchers from community testing for COVID-19.

11 Jan 2022

Latest tools for COVID-19 Omicron variant research

AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2.

From AMS Biotechnology 11 Jan 2022

Optimal monoclonal antibodies against SARS-CoV-2 variants

Researchers screen different monoclonal antibodies to identify an optimal mAb with higher binding affinity to the receptor-binding domain of SARS-CoV-2.

10 Jan 2022

Modeling shows that free SARS-CoV-2 rapid antigen tests for all Australians would benefit the economy

Researchers conducted a cost-effectiveness analysis of government-funded COVID-19 rapid antigen tests in Australia.

10 Jan 2022

Unrelated vaccines could also help reduce the burden of COVID-19 pandemic, study shows

While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.

10 Jan 2022

SARS-CoV-2 Delta binds more strongly to furin protease than other existing variants

Researchers conducted a computational analysis of the furin cleavage domain (FCD) of SARS-CoV-2 and its variants, as well as several other viruses.

10 Jan 2022

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

The public's willingness to comply with Centers for Disease Control and Prevention recommendations correlates with COVID-19 case projections in zip codes where those surveyed about their intended behaviors live, according to Penn State College of Medicine researchers.

10 Jan 2022

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Researchers screened BNT162b2 COVID-19 vaccine recipients and cloned broadly neutralizing antibodies from an elite vaccinee.

10 Jan 2022

Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

In a new study, researchers evaluated the neutralizing power of the vaccine against SARS-CoV-2 and vaccine plus infection-induced antibodies against the Omicron variant in a live virus neutralization assay.

10 Jan 2022

Effectiveness of prior infection in preventing reinfection with Omicron and other SARS-CoV-2 variants in Qatar

Researchers estimate the effectiveness of prior infection in preventing reinfection (PEs) with Omicron and other SARS-CoV-2 variants for the resident population of Qatar.

10 Jan 2022

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells.

10 Jan 2022

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

In a new study, researchers determined three-dose messenger ribonucleic acid (mRNA) vaccinated kidney transplant recipients’ (KTRs) neutralizing responses against SARS-COV-2 variants, breakthrough coronavirus disease 2019 infection rate, and transplant rejection rate.

10 Jan 2022

Incidence rates of psychiatric diagnoses and drugs in Israeli adolescents before and during the COVID-19 pandemic

Researchers investigated the incidence of psychiatric diagnoses of Israeli adolescents before and during the COVID-19 pandemic.

10 Jan 2022

New molecule offers effective protection against coronavirus for at least eight hours

A molecule developed by researchers at the University of Helsinki can inactivate the coronavirus spike protein and offers effective short-term protection against the virus.

10 Jan 2022

Omicron News and Research

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

Evaluating effectiveness of the COVID-19 mRNA-1273 vaccine against Omicron and Delta variants

Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant

Fire closes hospital and displaces staff as Colorado battles omicron

Development and validation of 2-gene host-based COVID-19 diagnostic classifiers

Providing recombinant antibody services and more within Europe

New insights into reforming the actions that hindered Seattle researchers from community testing for COVID-19

Latest tools for COVID-19 Omicron variant research

Optimal monoclonal antibodies against SARS-CoV-2 variants

Modeling shows that free SARS-CoV-2 rapid antigen tests for all Australians would benefit the economy

Unrelated vaccines could also help reduce the burden of COVID-19 pandemic, study shows

SARS-CoV-2 Delta binds more strongly to furin protease than other existing variants

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

Effectiveness of prior infection in preventing reinfection with Omicron and other SARS-CoV-2 variants in Qatar

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

Incidence rates of psychiatric diagnoses and drugs in Israeli adolescents before and during the COVID-19 pandemic

New molecule offers effective protection against coronavirus for at least eight hours

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News